These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Serious neurologic complications secondary to intrathecal injections of antineoplastic agents]. Corberand J; Pris J; Robert A; Monnier J; Regnier C Arch Fr Pediatr; 1973 Feb; 30(2):177-88. PubMed ID: 4515472 [No Abstract] [Full Text] [Related]
3. Paraplegia following intrathecal chemotherapy: neuropathologic findings and elevation of myelin basic protein. Clark AW; Cohen SR; Nissenblatt MJ; Wilson SK Cancer; 1982 Jul; 50(1):42-7. PubMed ID: 6177392 [TBL] [Abstract][Full Text] [Related]
4. Paraplegia after intrathecal administration of methotrexate. Ulukutlu L; Yildiz I; Uğur S; Keskin S Turk J Pediatr; 1983; 25(3):167-74. PubMed ID: 6585082 [No Abstract] [Full Text] [Related]
6. Intrathecal mitozantrone has to be prohibited. Dalle JH; Lambilliotte A; Defachelles AS; Mazingue F; Nelken B Leukemia; 2000 Dec; 14(12):2323-4. PubMed ID: 11187924 [No Abstract] [Full Text] [Related]
7. [Neurologic accidents after subarachnoid injection of CaCl 2 and KCl]. Bismuth C; Pebay-Peyroula F; Mendez J Eur J Toxicol; 1971; 4(4):328-30. PubMed ID: 5292078 [No Abstract] [Full Text] [Related]
8. Complications of intrathecal methotrexate prophylaxis and treatment of central nervous system leukemia in children. Kobayashi Y; Ishigame Y; Hara M; Nitta Y; Higaki T Hiroshima J Med Sci; 1976 Sep; 25(2-3):107-13. PubMed ID: 1071901 [No Abstract] [Full Text] [Related]
9. Paraplegia following intrathecal chemotherapy. Saiki JH; Thompson S; Smith F; Atkinson R Cancer; 1972 Feb; 29(2):370-4. PubMed ID: 4552135 [No Abstract] [Full Text] [Related]
13. [Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy (author's transl)]. Aur JA; Simone JV; Verzosa MS; Hustu HO; Pinkel DP; Barker LF Sangre (Barc); 1978; 23(1):1-12. PubMed ID: 273309 [No Abstract] [Full Text] [Related]
14. Therapy-related leukemia in mitozantrone treated patients. Goodkin DE Mult Scler; 2003 Aug; 9(4):426. PubMed ID: 12926850 [No Abstract] [Full Text] [Related]
15. Warning against use of intrathecal mitoxantrone. Hall C; Dougherty WJ; Lebish IJ; Brock PG; Man A Lancet; 1989 Apr; 1(8640):734. PubMed ID: 2564552 [No Abstract] [Full Text] [Related]
16. Outcome of CNS leukemia. Markum AH; Abdulsalam M; Gatot J; Wahidiyat I; Muslichan S Paediatr Indones; 1980; 20(3-4):57-67. PubMed ID: 6931344 [No Abstract] [Full Text] [Related]
17. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature". Walter AW J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422 [No Abstract] [Full Text] [Related]
18. Sinus bradycardia secondary to mitoxantrone. Chan-Tack K Mo Med; 2000 Jun; 97(6):221. PubMed ID: 10870375 [No Abstract] [Full Text] [Related]
19. [Acute lymphoblastic leukemia. Preliminary study of 2 therapeutic regimens, one without prophylactic radiotherapy of central nervous system involvement]. Cabral E; Gomes Filho JM; Gansl RC; Silveira PA; Menosi SF; Zanichelli MA; Tobos K; Pozzi D Rev Hosp Clin Fac Med Sao Paulo; 1979; 34(5):222-6. PubMed ID: 297264 [No Abstract] [Full Text] [Related]